Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,701 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcription-polymerase chain reaction.
Chung I, Bresnick E. Chung I, et al. Arch Biochem Biophys. 1994 Oct;314(1):75-81. doi: 10.1006/abbi.1994.1413. Arch Biochem Biophys. 1994. PMID: 7524447
Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene.
Chung I, Bresnick E. Chung I, et al. Arch Biochem Biophys. 1997 Feb 15;338(2):220-6. doi: 10.1006/abbi.1996.9815. Arch Biochem Biophys. 1997. PMID: 9028875
Three protein binding sites were identified by DNase I footprinting analyses within the 259-bp sequence: protected region A PRA; -2283 to -2243 bp), PRB (-2218 to -2187 bp), and PRC (-2124 to -2098 bp) (I. Chung and E. Bresnick, Mol. Pharmacol. 47, 677-685, 1 …
Three protein binding sites were identified by DNase I footprinting analyses within the 259-bp sequence: protected region A PRA; -228 …
Regulation of the constitutive expression of the human CYP1A2 gene: cis elements and their interactions with proteins.
Chung I, Bresnick E. Chung I, et al. Mol Pharmacol. 1995 Apr;47(4):677-85. Mol Pharmacol. 1995. PMID: 7723729
Cytochrome P4501A2 (CYP1A2) is a member of the cytochrome P450 family that is involved in phase I drug metabolism in vertebrates. ...Using 5'-end deletion analysis, two functionally important cis elements, i.e., a proximal 42-bp DNA from bp -72 to bp -31 and a dista …
Cytochrome P4501A2 (CYP1A2) is a member of the cytochrome P450 family that is involved in phase I drug metabolism in vertebrates. ... …
Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo.
Montano R, Thompson R, Chung I, Hou H, Khan N, Eastman A. Montano R, et al. Among authors: chung i. BMC Cancer. 2013 Dec 21;13:604. doi: 10.1186/1471-2407-13-604. BMC Cancer. 2013. PMID: 24359526 Free PMC article.
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.
Montano R, Chung I, Garner KM, Parry D, Eastman A. Montano R, et al. Among authors: chung i. Mol Cancer Ther. 2012 Feb;11(2):427-38. doi: 10.1158/1535-7163.MCT-11-0406. Epub 2011 Dec 27. Mol Cancer Ther. 2012. PMID: 22203733 Free PMC article.
Previous studies with the topoisomerase I inhibitor SN38 have shown the efficacy of the Chk1 inhibitor UCN-01 to overcome this arrest and induce mitotic catastrophe. ...SCH900776 is currently in phase I clinical trials, and these results provide the rationale and sc …
Previous studies with the topoisomerase I inhibitor SN38 have shown the efficacy of the Chk1 inhibitor UCN-01 to overcome this arrest …
Magnetic resonance imaging based 3-dimensional printed breast surgical guide for breast-conserving surgery in ductal carcinoma in situ: a clinical trial.
Wu ZY, Alzuhair A, Kim H, Lee JW, Chung IY, Kim J, Lee SB, Son BH, Gong G, Kim HH, Seo JB, Ahn SH, Kim N, Ko B. Wu ZY, et al. Among authors: chung iy. Sci Rep. 2020 Oct 28;10(1):18534. doi: 10.1038/s41598-020-75398-7. Sci Rep. 2020. PMID: 33116237
microRNA-548m suppresses cell migration and invasion by targeting aryl hydrocarbon receptor in breast cancer cells.
Nor WMFSBW, Chung I, Said NABM. Nor WMFSBW, et al. Among authors: chung i. Oncol Res. 2020 Oct 27. doi: 10.3727/096504020X16037933185170. Online ahead of print. Oncol Res. 2020. PMID: 33109304
Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Gwark SC, Kim J, Lee CH, Kim YH, Kim MS, Hong SW, Choi MY, Jeon BH, Kwon NJ, Kim KY, Kim Y, Chang S, Yu JH, Park JY, Ahn JH, Jung KH, Kim SB, Lee HJ, Gong GY, Lee SB, Chung IY, Ko BS, Kim HJ, Lee JW, Son BH, Ahn SH. Gwark SC, et al. Among authors: chung iy. Sci Rep. 2020 Oct 15;10(1):17466. doi: 10.1038/s41598-020-74577-w. Sci Rep. 2020. PMID: 33060768 Free PMC article.
Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy.
Wu ZY, Kim HJ, Lee JW, Chung IY, Kim JS, Lee SB, Son BH, Eom JS, Kim SB, Jung KH, Gong G, Kim HH, Ahn SH, Ko B. Wu ZY, et al. Among authors: chung iy. JAMA Surg. 2020 Oct 14:e204132. doi: 10.1001/jamasurg.2020.4132. Online ahead of print. JAMA Surg. 2020. PMID: 33052412
Screening of Allelochemicals in Miscanthus sacchariflorus Extracts and Assessment of Their Effects on Germination and Seedling Growth of Common Weeds.
Ghimire BK, Hwang MH, Sacks EJ, Yu CY, Kim SH, Chung IM. Ghimire BK, et al. Among authors: chung im. Plants (Basel). 2020 Oct 5;9(10):E1313. doi: 10.3390/plants9101313. Plants (Basel). 2020. PMID: 33028036 Free article.
1,701 results
Jump to page
Feedback